Cytometry News and Research

RSS
People with CFS to benefit from Griffith’s National Centre for Neuroimmunology and Emerging Diseases

People with CFS to benefit from Griffith’s National Centre for Neuroimmunology and Emerging Diseases

New technique can diagnose cancer with high degree of accuracy, say researchers

New technique can diagnose cancer with high degree of accuracy, say researchers

Second edition of Antibodies: An essential resource for molecular biology, immunology, and cell culture lab

Second edition of Antibodies: An essential resource for molecular biology, immunology, and cell culture lab

Research suggests clingy blood platelets may offer hope for people with rheumatoid arthritis

Research suggests clingy blood platelets may offer hope for people with rheumatoid arthritis

CST introduces HER3 antibody for studying HER2-mediated breast, lung and ovarian tumors

CST introduces HER3 antibody for studying HER2-mediated breast, lung and ovarian tumors

New reagent kits for intracellular staining from Beckman Coulter Life Sciences

New reagent kits for intracellular staining from Beckman Coulter Life Sciences

Science Exchange partners with antibodies-online to independently validate antibodies to improve research quality

Science Exchange partners with antibodies-online to independently validate antibodies to improve research quality

Technique for developing more targeted drugs using molecular "robots"

Technique for developing more targeted drugs using molecular "robots"

Microfuge 20 and 20R microcentrifuges from Beckman Coulter Life Sciences simplify setup, offer increased speed and capacity

Microfuge 20 and 20R microcentrifuges from Beckman Coulter Life Sciences simplify setup, offer increased speed and capacity

Microparticle technique offers better control over kinetics of cell differentiation

Microparticle technique offers better control over kinetics of cell differentiation

Advanced genetics technologies may help predict patient outcomes in people with ALL

Advanced genetics technologies may help predict patient outcomes in people with ALL

Case Comprehensive Cancer Center secures "outstanding" rating from NCI

Case Comprehensive Cancer Center secures "outstanding" rating from NCI

New research shows uremic toxins increase heart attack risk

New research shows uremic toxins increase heart attack risk

New computational method may help track tumor progression, risk of relapse

New computational method may help track tumor progression, risk of relapse

Novel cell sorting enhancement to MoFlo Astrios platform to be introduced by Beckman Coulter Life Sciences at CYTO 2013

Novel cell sorting enhancement to MoFlo Astrios platform to be introduced by Beckman Coulter Life Sciences at CYTO 2013

DVS Sciences announces introduction of new products for single cell analysis

DVS Sciences announces introduction of new products for single cell analysis

BEAMing technology detects more mutations linked with secondary drug resistance in GIST patients

BEAMing technology detects more mutations linked with secondary drug resistance in GIST patients

Inflammation and epigenetics: an interview with Dr Belkina and Dr Denis, Boston University School of Medicine

Inflammation and epigenetics: an interview with Dr Belkina and Dr Denis, Boston University School of Medicine

UNM scientists identify chemical compound that appears to control cell metastases

UNM scientists identify chemical compound that appears to control cell metastases

Individualized flu immune responses revealed by high-throughput sequencing

Individualized flu immune responses revealed by high-throughput sequencing

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.